trial

Validating Reward-related Biomarkers (RTOC)

NCTId NCT04024371
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 160 (actual)
Sponsored by Maastricht University, School for Mental Health and Neuroscience
Primary completion 2021-02-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
160 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2019-09-16
Primary completion
2021-02-01
Eligibility
ALL · 20 Years · 55 Years

Interventions & indications

Drugs
Self-rating QuestionnairesMeasures of Reward processing/reinforcement learningAdditional Schizophrenia-specific Questionnaires and Interviews

Sponsors

Maastricht University, School for Mental Health and NeuroscienceLead Sponsor
P1vital Products LTD.Collaborator
BiotrialCollaborator
University Hospital Frankfurt, Department of Psychiatry, Psychosomatic Medicine and PsychotherapyCollaborator
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, BarcelonaCollaborator
Aristotle University Of ThessalonikiCollaborator
Maastricht University, School for Mental Health and NeuroscienceCollaborator

Investigators

1
Dennis Hernaus, PhDStudy Director

Sites

4 total
Frankfurt, GermanyThessaloniki, GreeceMaastricht, NetherlandsBarcelona, Spain

Facts & assertions

4 sourced
Enrollment
160
Phase
NA
Primary Completion Date
2021-02-01
Status
COMPLETED
relationships
The graph out of here
drug
Self-rating Questionnaires
drug
Measures of Reward processing/reinforcement learning
drug
Additional Schizophrenia-specific Questionnaires and Interviews
drug
lead_sponsor
Maastricht University, School for Mental Health and Neuroscience
company
collaborator
P1vital Products LTD.
company
Biotrial
company
indication
Anhedonia
indication
Anhedonia, Physical
indication
Depression
indication
investigator
Dennis Hernaus, PhD
person